Severino Michael
- SEC CIK
- 0001609447
No open-market purchases or sales filed in the past year.
Current role at each company
- SRPT Sarepta Therapeutics, Inc.Chief Executive Officeras of Jul 29, 2026
- AVTR Avantor, Inc.Directoras of May 11, 2026
- VTRS Viatris IncDirectoras of Mar 10, 2026
- ABBV AbbVie Inc.Vice Chairmanas of May 25, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Severino Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ABBV AbbVie Inc.
Vice Chairman3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2022 (view filing) | May 6-10 | 4 days | Severino MichaelVice Chairman | SSaleCommon Stock, $0.01 par value | −300.0K | $151.12 | −$45.3M | −66.4%152.1K after | 9 lots |
| May 18, 2022 (view filing) | May 16-17 | 2 days | Severino MichaelVice Chairman | SSaleCommon Stock, $0.01 par value | −200.0K | $154.25 | −$30.8M | −56.8%152.1K after | 6 lots |
| May 25, 2022 (view filing) | May 23 | 2 days | Severino MichaelVice Chairman | SSaleCommon Stock, $0.01 par value | −79.8K | $150.90 | −$12.0M | −34.4%152.1K after | 2 lots |